Target intelligence / Profile preview

HIV-1 capsid protein p24 (CA) (p24 (CA))

Target
p24 (CA)
Molecular classification
Viral structural protein, Capsid protein
01

Overview

The HIV-1 capsid protein p24 (CA), also known as Gag p24, is a 24 kDa major structural protein encoded by the gag gene, comprising approximately 1,500-3,000 molecules per virion. It forms a conical capsid shell around viral RNA and enzymes in mature virions through oligomerization of N-terminal (NTD with 7 α-helices and β-hairpin) and C-terminal (CTD with 4 α-helices) domains connected by a flexible linker. p24 mediates virion assembly, maturation, reverse transcription, nuclear import via interactions with nucleoporins and CPSF6, and host factors like cyclophilin A (at P90) and inositol hexaphosphate (IP6) for stability. Derived from proteolytic cleavage of the Pr55Gag polyprotein precursor, it is essential for viral replication cycle stages including assembly at plasma membrane, budding, and infectivity.

Other names
Gag p24CAcapsid protein CAp24 capsid protein
02

Biological functions

Houses viral RNA and core-associated proteinsMediates Gag multimerization and virion assemblyFacilitates reverse transcription and nuclear import of pre-integration complexInteracts with host factors like cyclophilin A and IP6 for stability and infectivity
03

Disease associations

Infection (HIV-1 replication and AIDS)
04

Safety considerations

Associated with drug resistance and treatment failure due to amino acid variations
05

Biomarkers

HIV-1 viral load indicatorDiagnostic marker for HIV-1 infection

Beyond the preview

Go deeper on HIV-1 capsid protein p24 (CA) (p24 (CA)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 capsid protein p24 (CA) (p24 (CA)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call